Hep C Virus - AVI BioPharma Stock Soars On Preclinical Flu Outcomes

AVI BioPharma Stock Soars On Preclinical Flu Outcomes
BioWorld Online (subscription), GA - Jan 20, 2006... Also this month, AVI offered favorable safety and pharmacokinetic results from the first part of a Phase I/II trial in chronic, active HCV. ...

Researchers Develop New Vaccine Candidate Against Hepatitis C
Infection Control Today, AZ - Jan 12, 2006... are yet available. VIDO is the first in Canada to show that this vaccination technique may be effective against HCV. The study was ...

Inovio Biomedical to Develop Vaccine for Hepatitis C in ...
Genetic Engineering News, NY - Jan 17, 2006... today that it has signed an agreement with Swedish-based Tripep AB (The Stockholm Exchange:TPEP) to develop a therapeutic vaccine for hepatitis C virus (HCV). ...

Genekam Biotechnology AG: The DNA-FluHunter Is The Best Weapon ...
Eworldwire (press release), NJ - Jan 13, 2006... Since 1999 DNA tests have been used to screen all blood transfusion samples in Germany for HIV, HBV and HCV, as there were reports of humans becoming infected ...

Migenix to start HCV drug trial in Q2
United Press International - Jan 23, 2006... it would begin a Phase 2b viral kinetics clinical trial of its first-in-class oral therapy MX-3253 (celgosivir) in patients with chronic hepatitis C virus (HCV ...